Lixoft Revenue and Competitors

Antony,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Lixoft's estimated annual revenue is currently $2.1M per year.(i)
  • Lixoft's estimated revenue per employee is $101,500

Employee Data

  • Lixoft has 21 Employees.(i)
  • Lixoft grew their employee count by 17% last year.

Lixoft's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$57.6M31824%N/AN/A
#2
$44.6M28623%$25.4MN/A
#3
$5.1M44-6%N/AN/A
#4
$35.1M225-3%$46.9MN/A
#5
$14.5M1005%N/AN/A
#6
$1.3M15-6%N/AN/A
#7
$1.5M170%N/AN/A
#8
$2.9M29-12%N/AN/A
#9
$125.2M6916%N/AN/A
#10
$95.9M529-1%N/AN/A
Add Company

What Is Lixoft?

Lixoft develops modeling and simulation software for advanced model-based drug development, and offers powerful and easy solutions for population analysis in pre-clinical and clinical trials, pharmacovigilance and pharmacoepidemiology. Lixoft allows the deployment of the most advanced mathematical models in pharmacology, by combining breakthough statistical methods with unique ease of use. The Lixoft products advance translational medicine with communication-enabling tools for a shared ownership all across the drug development continuum.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$2.1M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lixoft News

2022-04-20 - Zacks: Analysts Expect Simulations Plus, Inc. (NASDAQ:SLP) Will Announce Earnings of $0.17 Per Share

It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. Featured Articles. Get a free copy of the StockNews.com...

2022-04-19 - Simulations Plus Successfully Delivers FDA-Funded Project

Jonathan Chauvin, President of the Lixoft division at Simulations Plus, said: “Our efficient NCA calculation engine in PKanalix, with our...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.9M4011%N/A
#2
N/A4429%N/A
#3
N/A11822%N/A
#4
$37M1376%N/A
#5
$37.1M14819%N/A